Bioactive adrenomedullin and interleukin-6 in COVID-19: potential biomarkers of acute kidney injury and critical illness

The aim of this study was to investigate whether bioactive adrenomedullin (bio-ADM) and interleukin-6 (IL-6) are related to acute kidney injury (AKI) and severe illness in COVID-19 patients.

Source: BMC Nephrology - February 9, 2024 Category: Urology & Nephrology Authors: Simon B. Leininger, Stephan T. Staudner, Manuel J. Vogel, Julian Mustroph, Ute Hubauer, Stefan Wallner, Petra Lehn, Ralph Burkhardt, Christine Meindl, Frank Hanses, Markus Zimmermann, Lars S. Maier, Julian Hupf and Carsten G. Jungbauer Tags: Research Source Type: research